532039 Stock Overview
Zenotech Laboratories Limited provides pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Zenotech Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹68.57 |
| 52 Week High | ₹81.00 |
| 52 Week Low | ₹49.60 |
| Beta | 0.18 |
| 1 Month Change | 15.11% |
| 3 Month Change | -5.24% |
| 1 Year Change | 24.36% |
| 3 Year Change | 61.72% |
| 5 Year Change | 225.75% |
| Change since IPO | -39.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532039 | IN Biotechs | IN Market | |
|---|---|---|---|
| 7D | 3.8% | 9.3% | 1.8% |
| 1Y | 24.4% | 24.1% | 46.4% |
Return vs Industry: 532039 matched the Indian Biotechs industry which returned 24.1% over the past year.
Return vs Market: 532039 underperformed the Indian Market which returned 46.4% over the past year.
Price Volatility
| 532039 volatility | |
|---|---|
| 532039 Average Weekly Movement | 6.4% |
| Biotechs Industry Average Movement | 6.1% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 532039 has not had significant price volatility in the past 3 months.
Volatility Over Time: 532039's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 150 | Devendra Chandrakant Kenkre | www.zenotechlab.com |
Zenotech Laboratories Limited provides pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India. It manufactures biotechnology products, such as granulocyte-colony stimulating factors and granulocyte-macrophage colony-stimulating factors. Zenotech Laboratories Limited was incorporated in 1989 and is based in Hyderabad, India.
Zenotech Laboratories Limited Fundamentals Summary
| 532039 fundamental statistics | |
|---|---|
| Market cap | ₹4.18b |
| Earnings (TTM) | ₹113.07m |
| Revenue (TTM) | ₹391.04m |
37.0x
P/E Ratio10.7x
P/S RatioIs 532039 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532039 income statement (TTM) | |
|---|---|
| Revenue | ₹391.04m |
| Cost of Revenue | ₹28.74m |
| Gross Profit | ₹362.30m |
| Other Expenses | ₹249.23m |
| Earnings | ₹113.07m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 01, 2024
| Earnings per share (EPS) | 1.85 |
| Gross Margin | 92.65% |
| Net Profit Margin | 28.92% |
| Debt/Equity Ratio | 0% |
How did 532039 perform over the long term?
See historical performance and comparison